BNET Industries
Market Cap:$148.4B
Last Fiscal Year Sales:$48.4B
- Public
- US
Dow Jones Description
Taking care of you and your four-legged friends too! Pfizer Inc. (NYSE: PFE), based in New York, NY, discovers, develops, manufactures and sells prescription medications for humans and animals. Employing about 115,000 people, this $51.3 billion company operates in three segments: Human Health, Consumer Healthcare and Animal Health. Together, these segments cover treatments for diseases such as cardiovascular and metabolic diseases, medications for oral care, tobacco dependence, and products for prevention and treatment of diseases in livestock and pets.
Number of Employees 81,800
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
Pfizer Raises Quarterly Dividend 13%, See More Annual Hikes
-
REG-Pfizer Inc Pfizer Declares an 18-Cent First-Quarter 2010 Dividend
-
BRIEF: SEC probing insider-trading allegations
-
Pfizer joins partnership with Calif. firm: Collaboration planned with Crown Bioscience for cancer research
-
Research and Markets: The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to...
-
Science and Technology: Pfizer to buy Croatian drug patent
-
Bristol-Myers Squibb Raises Exchange Offer Price For Mead Johnson Shares - Update
-
'IT boosts efficiency & innovation'
-
Inspector General Saved Billions in Healthcare This Year
-
Private security firms no longer able to provide police information checks
-
Reportlinker Adds Growth Factors Blood And Tissue - A World Report
-
Market Report -- In Play PFE
-
Protalix Completes NDA Submission for taliglucerase alfa for the Treatment of Gaucher's Disease
-
Pfizer Inc. PFE JOBS Acquires Rights to Protalix Biotherapeutics's Gaucher Drug in Deal Worth $115M
-
Conservationists salute two corporations
-
Pfizer PFE Will Not Renew Ethical Distribution Agreement Term with MWI Veterinary Supply MWIV
-
2009: The Year That Was For Pfizer
-
A 2nd Loss for Pfizer in Drug Suits
-
Pfizer acquires stem cell therapies assets of Axordia
News & Analysis
Filter by
board and pfizer inc. - All News and Analysis
The 10 Weirdest Drug Stories of the Month
BNET
- 2009-02-27
It's that time again -- another month is done. Here's your roundup of the strange stuff that didn't quite make the front page. Boffins comb old Bayer plant and find abandoned legless robot The Hartford Courant: Jeffrey Townsend, an evolutionary biologist, made his way...
/ CORRECTION - Bilcare Global Clinical Supplies Forms Corporate Advisory Board; Inducts Former Pfizer President and the Executive Director of Waterloo Institute of Nanotechnology as Members
- 2008-05-01
In the news release, "Bilcare Global Clinical Supplies Forms Corporate Advisory Board; Inducts Former Pfizer President and the Executive Director of Waterloo Institute of Nanotechnology as Members," issued earlier today by Bilcare, we are advised by the company that the fifth sentence of the second paragraph should read "Dr. LaMattina...
Bilcare Global Clinical Supplies Forms Corporate Advisory Board; Inducts Former Pfizer President and the Executive Director of Waterloo Institute of Nanotechnology as Members
- 2008-04-30
Bilcare Global Clinical Supplies, a leading single-source provider of clinical trial services, has formed its first corporate Advisory Board. Bilcare Limited's Chairman and Managing Director Mohan Bhandari announced former Pfizer President John LaMattina, Ph.D., and Waterloo Institute of Nanotechnology Executive Director Arthur Carty, Ph.D., D.Sc., as the board's inaugural members....
TheSubway.com: Stock Market Alerts for Thursday, January 17, 2008: FEED Heavy Hitters Joining Board!
- 2008-01-17
M2 PRESSWIRE-17 January 2008-TheSubway.com: TheSubway.com: Stock Market Alerts for Thursday, January 17, 2008: FEED Heavy Hitters Joining Board!C1994-2008 M2 COMMUNICATIONS LTD RDATE:17012008 TheSUBWAY.com: Names the following stocks to its Stock Alerts List: AgFeed Industries, Inc. (NASDAQ: FEED), Cisco (NASDAQ: CSCO), MobiClear,...
Two New Directors Elected to Pfizer Board
- 2007-09-27
NEW YORK -- Pfizer Inc announced today the election of Suzanne Nora Johnson and James M. Kilts to the Pfizer Board of Directors effective September 27, 2007.
New Directors Elected to California Healthcare Institute Board
- 2007-09-05
LA JOLLA, Calif. -- The California Healthcare Institute CHI today announced the election of Hans Bishop, head of the Hematology/Cardiology Business Unit of Bayer HealthCare Pharmaceuticals, based in Berkeley, Calif., and Catherine J. "Kitty" Mackey, Ph.D., senior vice president of Pfizer Global Research and Development, site director of Pfizer's research...
Victor P. Micati Joins OLIGOMERIX's Board of Directors
- 2007-08-08
NEW YORK -- OLIGOMERIX Inc. today announced that Victor P. Micati has been appointed to the Company's Board of Directors. A global pharmaceutical executive, Mr. Micati worked at Pfizer Inc. (NYSE:PFE) for nearly 40 years. He was a member of Pfizer's 10-member Corporate Management Committee responsible for all aspects of...
Pfizer Board of Directors to Initiate Face-to-Face Meetings with Company's Institutional Investors on Corporate Governance Policies and Practices
- 2007-06-28
Commitment Enhances Long-Standing Focus on Highest Governance Standards
PFIZER INC - Pfizer Board new Lead Director.
- 2007-02-23
Pfizer Board of Directors Elects Constance J. Horner to Serve as Lead Director NEW YORK, Feb. 23 -- Pfizer said today that Constance J. Horner, a member of the company's Board of Directors since 1993, has been elected lead director effective...
Ludlow China Targets Skystar Bio-Pharmaceutical at $2.50.
- 2007-02-09
M2 PRESSWIRE-9 February 2007-InvestSource Inc.: Ludlow China Targets Skystar Bio-Pharmaceutical at $2.50C1994-2007 M2 COMMUNICATIONS LTD RDATE:09022007 Stocks in the News: Physicians Adult Daycare, Inc. (OTC: PHYA), Skystar Bio-Pharmaceutical Company (OTC BB: SKBI), Corautus Genetics Inc. (NASDAQ: VEGF), Pfizer Inc. (NYSE:...
Industry Transcripts by Seeking Alpha
-
Peregrine Pharmaceuticals Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Dec 10, 2009about PPHM
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- More Tysabri Problems; Time for a Biogen-Idec Credibility Check 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
- Why J&J's Stelara Launch Should Target Dermatologists First 3 votes
Presented by American Express